Updates from The Motley Fool

Latest updates on Insys Therapeutics from  The Fool has written over 100 articles on Insys Therapeutics.
5 Biotech Predictions for 2016

Image source: Flickr user Few industries see change as rapidly as biotech, and ...

3 Stocks the Market Loves to Hate

Everybody loves a market darling -- stocks so adored that their underlying businesses can seem to...

Stock Performance

View Interactive INSY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Insys Therapeutics.
Current Price: $11.52
Prev Close: $11.85
Open: $11.90
Bid: $11.45
Ask: $11.52
Day's Range: $11.45 - $12.05
52wk Range: $10.59 - $33.88
Volume: 386,541
Avg Vol 788,258
Market Cap: $830M
P/E (ttm): 17.95
EPS (ttm): $0.66
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Insys Therapeutics.
CAPS Rating 2 out of 5
61 Outperform
10 Underperform
CAPS All Stars
9 Outperform
9 Underperform

How do you think Insys Therapeutics will perform against the market?

You pick for Insys Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dr. John Kapoor,PhD, CEO

26% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Insys Therapeutics.


  • Exchange: NASDAQ